NEW YORK, April 8, 2025 /PRNewswire/ — ProofPilot, the leading end-to-end Clinical Experience Platform (CXP), is proud to announce that its Chief Strategy Officer, Joseph Kim, has been appointed to the Leadership Council for the Society for Clinical Research Sites (SCRS). In this role, Kim will collaborate with industry leaders to advance initiatives that empower and support clinical research sites.
The SCRS Leadership Council brings together executives from clinical research sites, pharmaceutical sponsors, contract research organizations (CROs) and industry service providers to provide strategic guidance, policy decisions, and oversight for SCRS. As a recognized thought leader in the clinical research industry, Kim will contribute valuable perspectives from his decades of experience in digital health and clinical innovation.
“I’m honored to join the SCRS Leadership Council and contribute to the vital work of strengthening and supporting research sites,” said Joseph Kim. “I look forward to working alongside fellow council members to advocate for the needs of sites and, ultimately, impact clinical research outcomes.”
ProofPilot is committed to making clinical trials easier for research sites with its clinical experience platform, which reduces trial complexity and alleviates site burden with centralized tasks, technologies, and instructional content. By aligning with SCRS’s advocacy and initiatives, ProofPilot continues to reinforce its mission of making clinical trials more accessible, efficient, and successful.
About ProofPilot
ProofPilot is a comprehensive Clinical Experience Platform (CXP) that redefines the design, management, and execution of clinical trials through digital innovation. With over 10 years of experience, ProofPilot’s CoPilot platform supports a wide range of research, making clinical trials more efficient and patient-friendly. Learn more at https://www.proofpilot.com and connect with us on LinkedIn.
Media Contact
Hope McCain, hope.mccain@proofpilot.com
SOURCE ProofPilot
SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…
The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…
BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…
CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…
MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…
Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…